Jeronimo, Christiane Maria Prado; Farias, Maria Eduarda Leao; Val, Fernando Fonseca Almeida; Sampaio, Vanderson Souza; Alexandre, Marcia Almeida Araujo; Melo, Gisely Cardoso; Safe, Izabella Picinin; Borba, Mayla Gabriela Silva; Abreu Netto, Rebeca Linhares; Maciel, Alex Bezerra Silva; Hajjar, Ludhmila Abrahão 
Source: Clinical infectious diseases. Unidade: FM
Subjects: PACIENTES INTERNADOS, COVID-19, HORMÔNIOS DO CÓRTEX ADRENAL, ANTI-INFLAMATÓRIOS, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JERONIMO, Christiane Maria Prado et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clinical infectious diseases, v. 72, n. 9, p. E373-E381, 2021Tradução . . Disponível em: https://doi.org/10.1093/cid/ciaa1177. Acesso em: 30 set. 2024.APA
Jeronimo, C. M. P., Farias, M. E. L., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., et al. (2021). Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clinical infectious diseases, 72( 9), E373-E381. doi:10.1093/cid/ciaa1177NLM
Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Abreu Netto RL, Maciel ABS, Hajjar LA. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial [Internet]. Clinical infectious diseases. 2021 ; 72( 9): E373-E381.[citado 2024 set. 30 ] Available from: https://doi.org/10.1093/cid/ciaa1177Vancouver
Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Abreu Netto RL, Maciel ABS, Hajjar LA. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial [Internet]. Clinical infectious diseases. 2021 ; 72( 9): E373-E381.[citado 2024 set. 30 ] Available from: https://doi.org/10.1093/cid/ciaa1177
